financetom
Business
financetom
/
Business
/
Top 10 issuers dominate US active ETF marketplace, Morningstar says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top 10 issuers dominate US active ETF marketplace, Morningstar says
Apr 23, 2024 6:40 AM

April 23 (Reuters) - Assets invested in actively managed

U.S. exchange traded funds soared 15% to $611 billion in the

first quarter, Morningstar said in a report published on

Tuesday, but the vast majority of that money flowed into funds

managed by a handful of issuers.

A team of Morningstar analysts headed by Bryan Armour and

Ryan Jackson described the market as "lopsided" and calculated

the top 10 issuers of active ETFs controlled 74% of assets.

The remaining 310 firms that also have rolled out actively

managed ETFs have done so with comparatively "limited success,"

the analysts said.

"I would have anticipated more breadth and depth" among

market leaders, given the overall growth in active ETFs, Armour

said in an interview ahead of the report's publication.

When the U.S. Securities and Exchange Commission approved a

rule change making the launch of active ETFs as simple as

index-based products five years ago, the category represented

only 2% of roughly $4 trillion in U.S. ETF assets.

While the size of the market has since doubled to just north

of $8 trillion, active ETFs now represent 8.5% of those assets,

Morningstar noted, up from 7% at this point last year.

The biggest winners tend to be large asset managers that are

relatively new entrants to ETFs, the Morningstar report found.

That list includes JP Morgan, Dimensional Fund Advisors

and Capital Group, all of which have parlayed strong mutual fund

track records into above-average growth in ETF market share.

The JPMorgan Equity Premium Income ETF has been one

of the most successful ETFs ever, attracting more than $33

billion in inflows since its May 2020 launch, according to data

from VettaFi.

"Issuers that have been aggressive in cutting fees or

offering low-fee active ETFs have also won market share," Armour

said.

Despite the success of the larger asset managers, new

entrants are continuing to join the ETF market.

"We're still in the very early days for active ETFs," said

Matt Kaufman, head of ETFs at Calamos Investments, an

established asset manager that launched its first ETFs in 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Terex Launches $750 Million Senior Notes Offering
Terex Launches $750 Million Senior Notes Offering
Sep 30, 2024
09:13 AM EDT, 09/30/2024 (MT Newswires) -- Terex ( TEX ) said Monday it intends to sell $750 million of senior notes due 2032 in a private offering. The company said it plans to use the proceeds from the offering, together with new term loan borrowings and cash on hand, to complete its proposed acquisition of Dover's (DOV) subsidiaries and...
Russia fines Google, Discord over banned content
Russia fines Google, Discord over banned content
Sep 30, 2024
MOSCOW, Sept 30 (Reuters) - Russia fined Alphabet's Google and instant messaging platform Discord on Monday for failing to delete or restrict access to information online, the Moscow courts' press service said. Russia has for several years ordered foreign technology platforms to remove content it deems illegal, issuing small, but persistent fines when it sees failures to comply. Moscow's Tagansky...
BRIEF-Vishay Precision Group Acquires Nokra
BRIEF-Vishay Precision Group Acquires Nokra
Sep 30, 2024
Sept 30 (Reuters) - Vishay Precision Group Inc ( VPG ): * VISHAY PRECISION GROUP ACQUIRES NOKRA * VISHAY PRECISION GROUP INC ( VPG ): TERMS OF TRANSACTION WERE NOT DISCLOSED * VISHAY PRECISION GROUP INC ( VPG ) - TERMS OF TRANSACTION WERE NOT DISCLOSED * VISHAY PRECISION GROUP INC ( VPG ) - TERMS OF VISHAY-NOKRA DEAL NOT...
INmune Bio Closes Enrollment for Phase 2 XPro Trial in Early Alzheimer's Disease
INmune Bio Closes Enrollment for Phase 2 XPro Trial in Early Alzheimer's Disease
Sep 30, 2024
09:10 AM EDT, 09/30/2024 (MT Newswires) -- INmune Bio ( INMB ) said Monday it closed the enrollment of a phase 2 trial involving patients with early Alzheimer's Disease and elevated neuroinflammation. INmune said it determined that they've enrolled enough patients to meet the study's target of 201 individuals, which will be evaluated with the company's investigational XPro treatment. Price:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved